USC Norris Comprehensive Cancer Center

An NCI-designated Comprehensive Cancer Center


Senior Leadership

Screen Shot 2020-11-03 at 2.44.23 PM

Caryn Lerman, PhD

Director, USC Norris Comprehensive Cancer Center

James Amatruda, MD, PhD

Interim Associate Director, Pediatric Oncology


Vasiliki Anest, PhD

Chief Innovation Officer

Lourdes Baezconde-Garbanati earns AACR Distinguished Lectureship

Lourdes Baezconde-Garbanati, MPH, PhD

Associate Director,
Community Outreach & Engagement

Yali Dou, PhD

Associate Director, Basic Research

David Conti, PhD

Associate Director, Data Science

Josh Neman-Ebrahim, PhD

Associate Director, Cancer Research Training and Education


Anthony B. El-Khoueiry, MD

Associate Director, Clinical Research


Chanita Hughes-Halbert, PhD

Associate Director, Cancer Equity


Amir Goldkorn, MD

Associate Director, Translational Research

grossman news

Steven Grossman, MD, PhD

Deputy Director for Cancer Services

Lenz 3

Heinz-Josef Lenz, MD

Deputy Director for Research Programs


Christopher Loertscher, MA

Associate Director for Administration & Chief Administrative Officer


Jennifer Tsui, PhD

Director for Cancer Care Delivery Research and Implementation Science (CCD/IS)


Mariana Stern, PhD

Associate Director, Population Science

Joseph Wiemels, PhD

Associate Director, Shared Resources

Program Leaders

Epigenetic Regulation in Cancer

The program is led by Bodour Salhia, PhD, a translational genomics scientist with extensive knowledge and expertise in mechanisms that underlie tumorigenesis and tumor biology.

Tumor Immunology & Microenvironment

The program leaders are W. Martin Kast, PhD  who has recognized expertise in cancer virology, cancer immunology, and cancer immunotherapy, and Evanthia Roussos Torres, MD, PhD who has expertise in immune-oncology with a
specific interest in breast cancer and the tumor immune suppressive microenvironment. 

Evanthia Roussos Torres, MD, PhD


Translational and Clinical Sciences

The program leader Fumito Ito, MD, PhD  is a nationally recognized surgical oncologist and cancer researcher who has a significant clinical interest in melanoma, sarcoma, and breast cancer.

Fumito Ito, MD, PhD


Cancer Epidemiology

The program co-leaders, Wendy Setiawan, PhD, and Christopher Haiman, ScD, have complementary recognized expertise in cancer epidemiology and genetics, and immunology, biomarkers and biobanking, respectively.

Cancer Control Research

The program co-leaders, Myles Cockburn, PhD, and Jennifer Tsui, PhD, have complementary recognized expertise in cancer prevention and cancer survivorship.

Jennifer Tsui, PhD